Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients

Critical Need for International Consensus on Ototoxicity Assessment Criteria

(2010) Edward A. Neuwelt et al.   JOURNAL OF CLINICAL ONCOLOGY

Practical Grading System for Evaluating Cisplatin Ototoxicity in Children

(2010) Kay W. Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Hearing Loss in Pediatric Oncology Patients Receiving Carboplatin-containing Regimens

(2009) Jennifer B. Dean et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

(2009) Colin J D Ross et al.   NATURE GENETICS

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

(2009) D Caronia et al.   PHARMACOGENOMICS JOURNAL

Ototoxicity in children treated for osteosarcoma

(2008) Matthew J. Lewis et al.   PEDIATRIC BLOOD & CANCER